Home/Filings/4/0001181431-07-008133
4//SEC Filing

Simpson Carl 4

Accession 0001181431-07-008133

CIK 0001108271other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:08 PM ET

Size

12.9 KB

Accession

0001181431-07-008133

Insider Transaction Report

Form 4
Period: 2007-02-01
Simpson Carl
Director
Transactions
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2007-02-01$19.13/sh12,600$241,0380 total
    Exercise: $14.37Exp: 2015-06-22Common Stock (12,600 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2007-02-01$32.31/sh31,500$1,017,7650 total
    Exercise: $1.19Exp: 2014-08-11Common Stock (31,500 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2007-02-01$33.21/sh84,000$2,789,6400 total
    Exercise: $0.29Exp: 2013-02-27Common Stock (84,000 underlying)
Footnotes (3)
  • [F1]This option, which partially vested in increments of one forty-eighth of the total shares subject to the option each month, was canceled pursuant to the terms of the Agreement and Plan of Merger, dated November 16, 2006, among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (the "Merger Agreement"), in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.
  • [F2]This option, which vested in increments of one forty-eighth of the total shares subject to the option each month, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.
  • [F3]This option, which vested in increments of one twelfth of the total shares subject to the option each quarter, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.

Documents

1 file

Issuer

CONOR MEDSYSTEMS INC

CIK 0001108271

Entity typeother

Related Parties

1
  • filerCIK 0001311197

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:08 PM ET
Size
12.9 KB